Patent ID: 11945868
Assignee: VISTERRA, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 23:
24. The antibody molecule of claim 1, wherein:
(a) the VH comprises: an HCDR1 comprising an amino acid sequence comprising the amino acid sequence of SEQ ID NO: 380, an HCDR2 comprising an amino acid sequence comprising the amino acid sequence of SEQ ID NO: 381, and an HCDR3 comprising the amino acid sequence of FVY; and
(b) the VL comprises: an LCDR1 comprising the amino acid sequence of SEQ ID NO: 352 or an amino acid sequence that differs by 1 conservative amino acid substitution therefrom, an LCDR2 comprising the amino acid sequence of SEQ ID NO: 353, and an LCDR3 comprising the amino acid sequence of SEQ ID NO: 354.